“…Iron carbonyls have been receiving rising interest due to their versatile applications in various areas, such as chemical synthesis, pharmaceuticals, and biology. Being inspired by the fact that the metallic active sites of hydrogenases (typically, [NiFe]‐hydrogenase, [FeFe]‐hydrogenase, and [Fe]‐hydrogenase) possess metal carbonyls, a huge number of nickel and iron carbonyls have been explored in an attempt of finding non‐noble‐metal catalysts for hydrogen evolution reaction (HER) 1–10 . Particularly, iron carbonyls are also efficient promoters in many organic reactions, for example, hydrogenation, hydrogen‐borrowing reactions, hydroboration, hydrosilylation, hydrophosphination, carbonylation, alkylation, cyclization reactions with C‐H cleavage and C‐C coupling, activation of unsaturated‐carbon bonds, et al 11–15 In the past decades or so, iron carbonyls as carbon monoxide‐releasing molecules (CORMs), 6,16,17 have emerged in gaseous medicine as CO is not only an important gaseous signaling molecule but also is of therapeutic effects in anti‐inflammatory, anti‐proliferation, anti‐apoptosis, anti‐hypoxia, vasodilatation, and protections from ischemia–reperfusion.…”